(Date:11/20/2008)... The National Minority ...Medical Association,s recent decision to develop a...ician and patient advocates to join the Forum in e...ance plans. , , "Physicians and lawyers -- ...y A. Puckrein, PhD, President and Chief Executive ...
(Date:11/20/2008)...e Johns Hopkins Bloomberg School of Public Health ...alf-day symposium to mark the 60th Anniversary of ...nt, "Public Health and Human Rights: The Work Ahea...and human rights over the last 60 years. , Navan...mmissioner for Human Rights will be the keynote sp...
(Date:11/20/2008)... Precision Therapeutics Inc., a le...se tests, has secured $43 million,in additional f...tion of,ChemoFx(R). ChemoFx is a diagnostic test...chemotherapeutic regimen for cancer patients. New...the round and was joined by existing,investors Ad...
(Date:11/20/2008)...PRNewswire/ -- The UNICEF supported clean-water,c...that water technology,manufacturer, The Watergeek...f,the campaign in 2009 -- the third year of this ...CEF provide clean water to children around the wor...a-based manufacturer will donate a,percentage of ...
Breaking Medicine News(10 mins):Health News:National Minority Quality Forum Applauds AMA's Health Insurer Code of Conduct 2Health News:Precision Therapeutics Secures $43 Million in Venture Capital Funding 2Health News:Precision Therapeutics Secures $43 Million in Venture Capital Funding 3Health News:TAP Project Partners With Watergeeks for 2009 Clean Water Campaign 2Health News:TAP Project Partners With Watergeeks for 2009 Clean Water Campaign 3(Date:11/20/2008)...Newswire-FirstCall/ -- Duska Therapeutics,Inc., ...t has submitted its,pivotal Phase 3 ATPace clinic...ocol Assessment (SPA) procedure with the U.S. Food...to securing an agreement with the FDA, Duska inten...d, placebo-controlled and randomized Phase 3,clin...
(Date:11/20/2008).../ -- Clinical data from a prospective,registry pr...um shows DVT,treatment with the Trellis(R) Periph...(Santa Clara, CA) successfully breaks up the blood... This technique, called isolated pharmacomechan...ly and safely than current catheter-directed throm...
(Date:11/20/2008)...20 The Scandinavian-based drug,de...sults of studies on its,lead antimicrobial candid...,the studies showed that the novel lytic peptidom...ignificantly better towards killing Staphylococcus...gold standard drugs. In,addition to this it has p...
(Date:11/19/2008)...9 Amgen,(Nasdaq: AMGN...subsidiary of,Takeda Pharmaceutical Company Limit...n the Phase 3 MONET1 trial evaluating motesanib (A...latin for the first-line treatment of,advanced no...ily suspended,following a planned safety data rev...
Breaking Medicine Technology:Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 2Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 3Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 4Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 2Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 3Lytix Presents LTX-109 Anti-Microbial Data at ICAAC 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 3Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 5Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 6Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 7The Bill 26 Melinda Gates Foundation BIO and Bio Ventures for Global Health Invite Proteome Systems CEO to Speak on TB Diagnostics Solutions At Par 3842 1The Bill 26 Melinda Gates Foundation BIO and Bio Ventures for Global Health Invite Proteome Systems CEO to Speak on TB Diagnostics Solutions At Par 3842 2The Bill 26 Melinda Gates Foundation BIO and Bio Ventures for Global Health Invite Proteome Systems CEO to Speak on TB Diagnostics Solutions At Par 3842 3Communication Intelligence Corporation Reports Fourth Quarter and Fiscal 2007 Results 2459 1Communication Intelligence Corporation Reports Fourth Quarter and Fiscal 2007 Results 2459 2Communication Intelligence Corporation Reports Fourth Quarter and Fiscal 2007 Results 2459 3Communication Intelligence Corporation Reports Fourth Quarter and Fiscal 2007 Results 2459 4Communication Intelligence Corporation Reports Fourth Quarter and Fiscal 2007 Results 2459 5Communication Intelligence Corporation Reports Fourth Quarter and Fiscal 2007 Results 2459 6Marine bacterias mealtime dash is a swimming success 2456 1Marine bacterias mealtime dash is a swimming success 2456 2Marine bacterias mealtime dash is a swimming success 2456 3Jury Awards Mount Vernon Man 2440 1 Million After Medical Device Chars Heart 13974 1Jury Awards Mount Vernon Man 2440 1 Million After Medical Device Chars Heart 13974 2Jury Awards Mount Vernon Man 2440 1 Million After Medical Device Chars Heart 13974 3Jury Awards Mount Vernon Man 2440 1 Million After Medical Device Chars Heart 13974 4...of the American Society of,Clinical Oncology -- , ...maceuticals,Inc. (Nasdaq:SCLN) and Sigma-Tau S.p....didate thymalfasin (ZADAXIN(r), thymosin,alpha 1) ...l trial,treating patients diagnosed with stage IV ... cancer. Results showed that thymalfasin,in combin...
...m to Begin Third Quarter 2007, HAYWARD, Calif., Ju...ences Incorporated presented data from a dose-esca...nhibitor, tanespimycin,(KOS-953) in combination wi...of antitumor activity and tolerability in patients...ed following treatment,with multiple conventional ...
Other Medicine Technology:Kosan Presents Data on Lead Hsp90 Inhibitor, Tanespimycin, Showing,Promising Antitumor Activity in Multiple Myeloma at ASCO 2Kosan Presents Data on Lead Hsp90 Inhibitor, Tanespimycin, Showing,Promising Antitumor Activity in Multiple Myeloma at ASCO 3Kosan Presents Data on Lead Hsp90 Inhibitor, Tanespimycin, Showing,Promising Antitumor Activity in Multiple Myeloma at ASCO 4Kosan Presents Data on Lead Hsp90 Inhibitor, Tanespimycin, Showing,Promising Antitumor Activity in Multiple Myeloma at ASCO 5Kosan Presents Data on Lead Hsp90 Inhibitor, Tanespimycin, Showing,Promising Antitumor Activity in Multiple Myeloma at ASCO 6The Netmon remote monitoring service allows the the Shandon Pathcentre to be programmed and monitored from any location via modem and personal computer. The service enhances preventive maintenance c
Shandon HistoWave is the answer to rapid tissue processing. It reduces time for fixation, tissue processing, decalification, immunochemistry and special stains.
...andon Grosslab Senior Grossing Wokrstation is a du... workstation designed for gross examination and se... construction, 3 efficient ventilation systems and...r faucets, table rinses, disposals and dictation s...
The Shandon Grosslab Grossing Workstation comes in a bench top or stand alone design for the gross examination and sectioning of specimens.
Medicine Products: